Science & Technology
Fri, January 27, 2012
FRANKLIN, Tenn.--([ BUSINESS WIRE ])--MModal Inc.(NASDAQ/GS: MODL), a leading provider of clinical narrative capture services, Speech Understandinga" technology and clinical documentation workflow, today announced that it has entered into a strategic reseller and development relationship with Allscripts (NASDAQ: MDRX) for its speech and language understanding technology, which will be available in key solutions for Allscripts clients across all ambulatory and acute-care platforms. The relationship will provide capabilities to create content-rich, voice-driven narrative patient documentation within Allscripts electronic health record (EHR) systems.
"M*Modalas technology optimizes the physicianas ability to generate a detailed story very efficiently in our Enterprise EHR platform from either the workstation or a mobile device."
M*Modalas technology, based on its Speech Understandinga" and Natural Language Understanding (NLU) platform, will empower Allscripts market-leading EHRs, providing Allscripts clients with innovative new technology focused on making electronic health records easier to learn and use. The integration supports Allscripts commitment to offer flexible note-creation options.
In addition, Allscripts is incorporating the M*Modal technology into its mobility offerings including its Sunrise Mobilea" MD II product for on-the-go speech understanding capability. Using Sunrise Mobile for the iPad, physicians can view complete patient context, use real-time speech to create immediate and detailed progress reports and other clinical notes, and have this documentation available to drive actions in the Allscripts Sunrise Clinical Managera" system.
aWe are firmly committed to open software that delivers intuitive user experience and captures complete, accurate, and high-quality patient information,a said Glen Tullman, Chief Executive Officer of Allscripts. aM*Modalas technology optimizes the physicianas ability to generate a detailed story very efficiently in our Enterprise EHR platform from either the workstation or a mobile device.a
M*Modal's technology takes advantage of its cloud-based enterprise documentation platform to enable healthcare providers to speech-enable existing health information systems including EHRs, radiology information systems (RIS) and picture archiving and communication systems (PACS). Providers can use their voice, in addition to keyboard and mouse, to seamlessly interact with their desktop clinical applications, including the dictation of medical narrative and voice navigation within 3rd-party applications. Using this solution, providers can improve documentation efficiency and avoid difficulties associated with template-based point-and-click systems, augmenting discretely captured data with a narrative of the patient's story. This ultimately improves the quality of clinical documentation.
aAllscripts is a leader in EHR technology and a demonstrated innovator in the healthcare industry,a said Vern Davenport, Chairman and CEO of M*Modal. aWe are pleased to collaborate with Allscripts to bring its large enterprise physician user-base our innovative technology to generate meaningful, actionable clinical content in ways that respect how they want to document patient encounters. With more than 165,000 physicians using M*Modal technology and services, we are poised to provide even greater value to ambulatory providers and, ultimately, patients.a
About Allscripts
Allscripts(NASDAQ:[ MDRX ]) delivers the insights that healthcare providers require to generate world-class outcomes. The companyas Electronic Health Record, practice management and other clinical, revenue cycle, connectivity and information solutions create aConnected Community of Healtha" for physicians, hospitals and post-acute organizations. To learn more about Allscripts, please visit[ www.allscripts.com ], [ Twitter ], [ Facebook ] and [ YouTube ].
About M*Modal
M*Modal (NASDAQ/GS: MODL)is a leading provider of clinical narrative capture services, Speech Understandinga" technology and clinical documentation workflow. M*Modalas enterprise solutions a" including mobile voice capture devices, speech recognition, Natural Language Understanding, Web-based workflow platforms and global network of medical editors a" help healthcare facilities facilitate adoption of electronic health records (EHR), transition to ICD-10, improve patient care, increase physician satisfaction and lower operational costs. For more information, please visit [ www.mmodal.com ], Twitter, Facebook and YouTube.
Forward-Looking Statements
Information provided and statements contained in this press release that are not purely historical, such as statements regarding our expectations regarding our future business plans are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934 and the Private Securities Litigation Reform Act of 1995. Such forward-looking statements only speak as of the date of this press release and the Company assumes no obligation to update the information included in this press release. Statements made in this press release that are forward-looking in nature may involve risks and uncertainties. Accordingly, readers are cautioned that any such forward-looking statements are not guarantees of future performance and are subject to certain risks, uncertainties and assumptions that are difficult to predict, including, without limitation, specific factors discussed herein and in other releases and public filings made by the Company (including filings by the Company with the Securities and Exchange Commission). Although the Company believes that the expectations reflected in such forward-looking statements are reasonable as of the date made, expectations may prove to have been materially different from the results expressed or implied by such forward-looking statements. Unless otherwise required by law, the Company also disclaims any obligation to update its view of any such risks or uncertainties or to announce publicly the result of any revisions to the forward-looking statements made in this press release.
